Pharmacology Research & Perspectives

Pharmacology Research & Perspectives英文簡介

PR&P is jointly published by the American Society for Pharmacology and Experimental Therapeutics (ASPET), the British Pharmacological Society (BPS), and Wiley. PR&P is a bi-monthly open access journal that publishes a range of article types, including: target validation (preclinical papers that show a hypothesis is incorrect or papers on drugs that have failed in early clinical development); drug discovery reviews (strategy, hypotheses, and data resulting in a successful therapeutic drug); frontiers in translational medicine (drug and target validation for an unmet therapeutic need); pharmacological hypotheses (reviews that are oriented to inform a novel hypothesis); and replication studies (work that refutes key findings [failed replication] and work that validates key findings). PR&P publishes papers submitted directly to the journal and those referred from the journals of ASPET and the BPS

Pharmacology Research & Perspectives中文簡介

《Pharmacology Research & Perspectives》是一本由Wiley-Blackwell出版商出版的專業(yè)醫(yī)學期刊，該刊創(chuàng)刊于2013年，刊期6 issues/year，該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄。在中科院最新升級版分區(qū)表中，該刊分區(qū)信息為大類學科：醫(yī)學 4區(qū)，小類學科：藥學 4區(qū)；在JCR（Journal Citation Reports）分區(qū)等級為Q3。該刊發(fā)文范圍涵蓋藥學等領域，旨在及時、準確、全面地報道國內(nèi)外藥學工作者在該領域取得的最新研究成果、工作進展及學術動態(tài)、技術革新等，促進學術交流，鼓勵學術創(chuàng)新。2021年影響因子為2.963，平均審稿速度20 Weeks。

中科院分區(qū)最新升級版（當前數(shù)據(jù)版本：2021年12月最新升級版）

大類學科	分區(qū)	小類學科	分區(qū)	Top期刊	綜述期刊
醫(yī)學	4區(qū)	PHARMACOLOGY & PHARMACY 藥學	4區(qū)	否	否

JCR分區(qū)（當前數(shù)據(jù)版本：2021-2022年最新版）

JCR分區(qū)等級	JCR所屬學科	分區(qū)	影響因子
Q3	PHARMACOLOGY & PHARMACY	Q3	2.963

期刊指數(shù)

影響因子	h-index	Gold OA文章占比	研究類文章占比	OA開放訪問	平均審稿速度
2.963	--	95.58%	81.38%	開放	20 Weeks

IF值(影響因子)趨勢圖